Greenwood Capital Associates’s Encompass Health EHC Stock Holding History

Greenwood Capital Associates’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,750	Closed	-$222K	–	260
2025 Q3	$222K	Hold	1,750	–	–	0.03%	251
2025 Q2	$215K	Buy	+1,750	New	+$200K	0.03%	240
2024 Q1	–	Sell	-4,050	Closed	-$270K	–	255
2023 Q4	$270K	Hold	4,050	–	–	0.04%	228
2023 Q3	$272K	Hold	4,050	–	–	0.04%	227
2023 Q2	$274K	Hold	4,050	–	–	0.04%	222
2023 Q1	$219K	Hold	4,050	–	–	0.03%	223
2022 Q4	$242K	Buy	+4,050	New	+$220K	0.04%	200
2022 Q3	–	Sell	-6,411	Closed	-$286K	–	219
2022 Q2	$286K	Hold	6,411	–	–	0.05%	197
2022 Q1	$363K	Hold	6,411	–	–	0.1%	129
2021 Q4	$333K	Sell	6,411 -3,582	-36%	-$185K	0.05%	198
2021 Q3	$597K	Hold	9,993	–	–	0.09%	171
2021 Q2	$620K	Sell	9,993 -2,828	-22%	-$188K	0.09%	162
2021 Q1	$835K	Buy	+12,821	New	+$836K	0.13%	125

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Greenwood Capital Associates's EHC Position: Q4 2025 in Review

Greenwood Capital Associates sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 1,750 shares — an estimated $222K sold.

Greenwood Capital Associates first reported a position in EHC in Q1 2021 and held it in 13 quarters. The position peaked at $835K in Q1 2021. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

Greenwood Capital Associates reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
Greenwood Capital Associates sold 1,750 Encompass Health shares in Q4 2025, an estimated $222K.
Greenwood Capital Associates first reported a position in Encompass Health in Q1 2021 and held it in 13 quarters.
Greenwood Capital Associates's Encompass Health position peaked at $835K in Q1 2021.
594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Greenwood Capital Associates's 13F filing for Q4 2025, filed 26 Jan 2026.